Ariad Pharmaceuticals Inc fka ARIA

[grandma_of_jbraika]

The French study is obviously biased as stated by the French investigators themselves:

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=94745692

Though biased, the French study is very good and the following conclusion should be very helpful:

These results should promote an extreme vigilance especially in older pts with known CV risk factors that will need to be strictly controlled and monitored. A preventive anti-thrombotic prophylaxis might be useful since Ponatinib initiation.

Despite the small cohort(only 19 patients), despite the obvious caveats and bias of such a study as stated by the French investigators themselves, despite the French study is obviously biased and therefore the justification of its conclusion is questionable, the paid pumper/basher at Oppenheimer biasedly uses the questionable conclusion in support of the FDA's intentionally exaggerated SAE rates.

Despite the Oppenheimer pumper/basher is biased, the shorts are posting his/her biased report everywhere.
**************************
I am going to join a class action lawsuit against.

I hope the law firm might help me get $0.001 per 1,000 shares that are qualified for the class action.

That is a bit low.

You might get ten times that.

smile

Class action security lawsuits are the REAL FRAUD.

zip - BTW - I am a lawyer.